Orix IX
NYSE IX
$39.30 -0.96 (-2.38%)
At close: Sep 18, 2026 · 4:00 PM EDT

Orix (IX) EBT Margin Growth (3y) (2012 - 2026)

Analysis

Orix (IX) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Orix 44.18 Bn 44.51 Bn 4.68 Bn 3,312.00
2 Royalty Pharma 33.59 Bn 35.70 Bn - -5,319.00
3 Royal Gold 21.14 Bn 21.00 Bn 390.45 Mn 2,009.00
4 OR Royalties 6.88 Bn 6.81 Bn 82.22 Mn 4,001.00
5 Encore Capital 2.11 Bn 1.93 Bn 455.04 Mn 560.00
6 Atlanticus Holdings 1.41 Bn 851.50 Mn 686.46 Mn -214.00
7 Jefferson Capital 1.18 Bn 1.16 Bn - -
8 Lufax Holding 1.04 Bn -1.23 Bn - -1,966.00
9 Upbound 998.67 Mn 893.37 Mn 594.84 Mn -329.00
10 Metalla Royalty & Streaming 942.93 Mn 931.86 Mn 4.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,312.00
Mar 31, 2026 -1,565.00
Dec 31, 2025 184.00
Sep 30, 2025 1,867.00
Jun 30, 2025 649.00
Mar 31, 2025 -1,664.00
Dec 31, 2024 -1,668.00
Sep 30, 2024 1,260.00
Jun 30, 2024 54.00
Mar 31, 2024 3,706.00
Dec 31, 2023 553.00
Sep 30, 2023 176.00
Jun 30, 2023 63.00
Mar 31, 2023 1,803.00
Dec 31, 2022 -189.00
Sep 30, 2022 -1,071.00
Jun 30, 2022 -502.00
Mar 31, 2022 1,438.00
Dec 31, 2021 141.00
Sep 30, 2021 237.00